Social News
Author: Zhu Haiqi
2021-01-18 18:01
Last update date: 2021-01-18 18:04
The government advisory expert committee met today (18th). The convener of the committee, Liu Zexing, pointed out that 12 members agreed that Fosun and the German pharmaceutical company BioNTech’s development of a vaccine would benefit the public more than the risks, and would submit their recommendations to the Director of the Food and Health Bureau Chen At the beginning of the deliberation, relevant suggestions will be uploaded to the website of the authorities.
The government will ask for the latest data from pharmaceutical companies and the Norwegian government, and examine the data on the deaths of 29 local people after being vaccinated.
The first batch will arrive in Hong Kong at the end of February.
▼Protection rate side effects of Kexing, BioNTECH Fosun, AstraZeneca ▼
+2
+2
+2
The vaccine is 95% effective
Liu Zexing and another member Xu Shuchang met with reporters after the meeting. Liu Zexing said that in early January this year, Fosun and the German pharmaceutical company BioNTech vaccine application were received. A detailed meeting was held this afternoon, mainly considering the safety, efficacy and quality of the vaccine, including the third phase. Clinical data, and the vaccine is 95% effective for people over 16 years old.
The committee will also consider vaccine clinical research data, poor proportions after inoculation in other places, vaccine formulations, production quality management practices (GMP), continuous information updates, opinions from overseas institutions, and follow-up supervision after the vaccine is launched.
Liu Zexing pointed out that 12 members agreed that the benefits of the BioNTech vaccine outweigh the risks, and will refer the recommendations to Chen Zhaoshi for consideration. To enhance the transparency of vaccine information, the relevant recommendations will be uploaded to the Food and Health Bureau website for public reference. The Department of Health has also established a "new crown Vaccine clinical event evaluation expert committee" to follow up every vaccine-related adverse reaction or clinical evaluation case after the local vaccine is launched. The department of infection, hematology, brain medicine and immunology of the university and the Hospital Authority will follow up the vaccine For quality and safety, if the committee believes that the risks outweigh the benefits, it will appropriately follow up, including cancellation of approval.
▼Social distancing measures will continue until January 20▼
+8
+8
+8
Twenty-nine people in Norway died after being vaccinated. The local cause of death of 13 people was related to the vaccine.
Liu Zexing stated that he would ask for information from the pharmaceutical factory and the local government, including information on gender and age.
Interview｜Zeng Haohui is worried about swine flu piracy, citizens are not confident about getting a new crown vaccine, experts must explain quickly
Interview｜BioNTech's new crown vaccine arrives in Hong Kong first, Haohui Zeng will be vaccinated pending clinical report purchase Kexing
New crown pneumonia vaccine | The first batch of vaccination is expected to start in February
Vaccine│Norway increased to 29 deaths after vaccination He Boliang: There is no evidence that there is a safety hazard
New crown pneumonia | Brazil approves emergency use of China Kexing and AstraZeneca vaccines
01News
New crown pneumonia new crown vaccine
